Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 1, Pages E41-E50Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1521248112
Keywords
endosidin2; exocytosis; exocyst; EXO70
Categories
Funding
- US Department of Energy [DE-FG02-02ER15295]
- National Aeronautics and Space Administration [NNX09AK82G]
- Grantova Agentura Ceske Republiky/Czech Science Foundation [15-14886S]
- Ministerstvo Skolstvi, Mladeze a Telovychovy Ceske Republiky [NPUI LO1417]
- U.S. Department of Energy (DOE) [DE-FG02-02ER15295] Funding Source: U.S. Department of Energy (DOE)
Ask authors/readers for more resources
The exocyst complex regulates the last steps of exocytosis, which is essential to organisms across kingdoms. In humans, its dysfunction is correlated with several significant diseases, such as diabetes and cancer progression. Investigation of the dynamic regulation of the evolutionarily conserved exocyst-related processes using mutants in genetically tractable organisms such as Arabidopsis thaliana is limited by the lethality or the severity of phenotypes. We discovered that the small molecule Endosidin2 (ES2) binds to the EXO70 (exocyst component of 70 kDa) subunit of the exocyst complex, resulting in inhibition of exocytosis and endosomal recycling in both plant and human cells and enhancement of plant vacuolar trafficking. An EXO70 protein with a C-terminal truncation results in dominant ES2 resistance, uncovering possible distinct regulatory roles for the N terminus of the protein. This study not only provides a valuable tool in studying exocytosis regulation but also offers a potentially new target for drugs aimed at addressing human disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available